261 related articles for article (PubMed ID: 15100288)
1. IL-4 protects tumor cells from anti-CD95 and chemotherapeutic agents via up-regulation of antiapoptotic proteins.
Conticello C; Pedini F; Zeuner A; Patti M; Zerilli M; Stassi G; Messina A; Peschle C; De Maria R
J Immunol; 2004 May; 172(9):5467-77. PubMed ID: 15100288
[TBL] [Abstract][Full Text] [Related]
2. Heterogenous susceptibility to CD95-induced apoptosis in melanoma cells correlates with bcl-2 and bcl-x expression and is sensitive to modulation by interferon-gamma.
Ugurel S; Seiter S; Rappl G; Stark A; Tilgen W; Reinhold U
Int J Cancer; 1999 Aug; 82(5):727-36. PubMed ID: 10417772
[TBL] [Abstract][Full Text] [Related]
3. Autocrine production of interleukin-4 and interleukin-10 is required for survival and growth of thyroid cancer cells.
Todaro M; Zerilli M; Ricci-Vitiani L; Bini M; Perez Alea M; Maria Florena A; Miceli L; Condorelli G; Bonventre S; Di Gesù G; De Maria R; Stassi G
Cancer Res; 2006 Feb; 66(3):1491-9. PubMed ID: 16452205
[TBL] [Abstract][Full Text] [Related]
4. Induction of apoptosis in 9-nitrocamptothecin-treated DU145 human prostate carcinoma cells correlates with de novo synthesis of CD95 and CD95 ligand and down-regulation of c-FLIP(short).
Chatterjee D; Schmitz I; Krueger A; Yeung K; Kirchhoff S; Krammer PH; Peter ME; Wyche JH; Pantazis P
Cancer Res; 2001 Oct; 61(19):7148-54. PubMed ID: 11585748
[TBL] [Abstract][Full Text] [Related]
5. Apoptosis resistance in epithelial tumors is mediated by tumor-cell-derived interleukin-4.
Todaro M; Lombardo Y; Francipane MG; Alea MP; Cammareri P; Iovino F; Di Stefano AB; Di Bernardo C; Agrusa A; Condorelli G; Walczak H; Stassi G
Cell Death Differ; 2008 Apr; 15(4):762-72. PubMed ID: 18202702
[TBL] [Abstract][Full Text] [Related]
6. Enhanced expression of Fas-associated death domain-like IL-1-converting enzyme (FLICE)-inhibitory protein induces resistance to Fas-mediated apoptosis in activated mast cells.
Yoshikawa H; Nakajima Y; Tasaka K
J Immunol; 2000 Dec; 165(11):6262-9. PubMed ID: 11086061
[TBL] [Abstract][Full Text] [Related]
7. NF-kappaB protects Behçet's disease T cells against CD95-induced apoptosis up-regulating antiapoptotic proteins.
Todaro M; Zerilli M; Triolo G; Iovino F; Patti M; Accardo-Palumbo A; di Gaudio F; Turco MC; Petrella A; de Maria R; Stassi G
Arthritis Rheum; 2005 Jul; 52(7):2179-91. PubMed ID: 15986355
[TBL] [Abstract][Full Text] [Related]
8. NF-kappa B is required for surface Ig-induced Fas resistance in B cells.
Schram BR; Rothstein TL
J Immunol; 2003 Mar; 170(6):3118-24. PubMed ID: 12626568
[TBL] [Abstract][Full Text] [Related]
9. Constitutive caspase activation and impaired death-inducing signaling complex formation in CD95-resistant, long-term activated, antigen-specific T cells.
Strauss G; Knape I; Melzner I; Debatin KM
J Immunol; 2003 Aug; 171(3):1172-82. PubMed ID: 12874203
[TBL] [Abstract][Full Text] [Related]
10. Stromal extracellular matrix reduces chemotherapy-induced apoptosis in colon cancer cell lines.
Kouniavsky G; Khaikin M; Zvibel I; Zippel D; Brill S; Halpern Z; Papa M
Clin Exp Metastasis; 2002; 19(1):55-60. PubMed ID: 11918083
[TBL] [Abstract][Full Text] [Related]
11. Mature dendritic cells are protected from Fas/CD95-mediated apoptosis by upregulation of Bcl-X(L).
Lundqvist A; Nagata T; Kiessling R; Pisa P
Cancer Immunol Immunother; 2002 May; 51(3):139-44. PubMed ID: 11941452
[TBL] [Abstract][Full Text] [Related]
12. Phosphorylation of Fas-associated death domain contributes to enhancement of etoposide-induced apoptosis in prostate cancer cells.
Shimada K; Nakamura M; Ishida E; Kishi M; Yonehara S; Konishi N
Jpn J Cancer Res; 2002 Oct; 93(10):1164-74. PubMed ID: 12417047
[TBL] [Abstract][Full Text] [Related]
13. Role of complement-binding CD21/CD19/CD81 in enhancing human B cell protection from Fas-mediated apoptosis.
Mongini PK; Jackson AE; Tolani S; Fattah RJ; Inman JK
J Immunol; 2003 Nov; 171(10):5244-54. PubMed ID: 14607925
[TBL] [Abstract][Full Text] [Related]
14. Sensitization of tumor cells to Apo2 ligand/TRAIL-induced apoptosis by inhibition of casein kinase II.
Ravi R; Bedi A
Cancer Res; 2002 Aug; 62(15):4180-5. PubMed ID: 12154014
[TBL] [Abstract][Full Text] [Related]
15. Mcl-1 mediates tumor necrosis factor-related apoptosis-inducing ligand resistance in human cholangiocarcinoma cells.
Taniai M; Grambihler A; Higuchi H; Werneburg N; Bronk SF; Farrugia DJ; Kaufmann SH; Gores GJ
Cancer Res; 2004 May; 64(10):3517-24. PubMed ID: 15150106
[TBL] [Abstract][Full Text] [Related]
16. Metabolic inhibitors sensitize for CD95 (APO-1/Fas)-induced apoptosis by down-regulating Fas-associated death domain-like interleukin 1-converting enzyme inhibitory protein expression.
Fulda S; Meyer E; Debatin KM
Cancer Res; 2000 Jul; 60(14):3947-56. PubMed ID: 10919673
[TBL] [Abstract][Full Text] [Related]
17. Dual upregulation of Fas and Bax promotes alloreactive T cell apoptosis in IL-10 gene targeting of cardiac allografts.
Tung TC; Oshima K; Cui G; Laks H; Sen L
Am J Physiol Heart Circ Physiol; 2003 Sep; 285(3):H964-73. PubMed ID: 12915385
[TBL] [Abstract][Full Text] [Related]
18. TCR-mediated up-regulation of c-FLIPshort correlates with resistance toward CD95-mediated apoptosis by blocking death-inducing signaling complex activity.
Kirchhoff S; Müller WW; Krueger A; Schmitz I; Krammer PH
J Immunol; 2000 Dec; 165(11):6293-300. PubMed ID: 11086065
[TBL] [Abstract][Full Text] [Related]
19. Expression of c-FLIP(L) and resistance to CD95-mediated apoptosis of monocyte-derived dendritic cells: inhibition by bisindolylmaleimide.
Willems F; Amraoui Z; Vanderheyde N; Verhasselt V; Aksoy E; Scaffidi C; Peter ME; Krammer PH; Goldman M
Blood; 2000 Jun; 95(11):3478-82. PubMed ID: 10828032
[TBL] [Abstract][Full Text] [Related]
20. Resistance of short term activated T cells to CD95-mediated apoptosis correlates with de novo protein synthesis of c-FLIPshort.
Schmitz I; Weyd H; Krueger A; Baumann S; Fas SC; Krammer PH; Kirchhoff S
J Immunol; 2004 Feb; 172(4):2194-200. PubMed ID: 14764686
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
